Poor Supplier Control Causing Recalls, FDA Says; Contract Is Key To Success
This article was originally published in The Silver Sheet
Executive Summary
SUPPLIER CONTROL PROBLEMS ARE ON THE RISE and may be contributing to an increase in medical device recalls, says FDA Quality Systems Expert Kim Trautman. "When the recalls come in and [firms are] identifying some of the causes for the recall, it seems to be more prevalent within the past five or so years that they are supplier issues," she notes. To combat the trend, FDA has begun emphasizing to industry the importance of complying with purchasing controls, as well as ensuring that supplier contracts adequately outline product and service requirements. "Sometimes the contracts and the expectations between the finished device manufacturer and the supplier are just too loose," Trautman says. Meanwhile, the agency admits it is having a tough time keeping up with "virtual manufacturing" and "internal supplying" arrangements...
You may also be interested in...
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.
FDA Slaps High Risk Class I Label On Recall Of COVID-19 Diagnostics Made In Uncontrolled Plant
More than 160,000 of the tests were recalled, including 104,900 COVID Test Kits Nonsterile and 61,500 Clean Catch Urine Kits.